Texcell
Business Services · Maryland, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4991 New Design Rd Ste 100, Frederick, M...Phone Number
(301) 363-5600Website
www.texcell.comRevenue
$15.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
3
1
1
About Texcell
Texcell is a leading specialist in therapeutic safety, partnering with clients to assess virus safety for biopharmaceuticals, including medical devices, biologics, and cell and gene therapies. Their services encompass custom cell culture, cell banking, viral safety, viral clearance studies, and both in vitro and in vivo bioassays. With a mission to enable customers to bring their therapeutic products to market with confidence, Texcell ensures the highest standards of virus safety. They are dedicated to protecting the health of patients worldwide through their biosafety services.Explore more
Texcell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Texcell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Texcell had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Texcell
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Texcell recently announced quarterly report
Texcell, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Texcell has new funding data
Product Launch: Get notified when Texcell launches new products
Check if Texcell has recently received funding, and reach out quickly before it becomes old news!
Check out if Texcell is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Texcell
Find more new buyers
Compare Similar Companies to Texcell
Compare insights from companies similar to Texcell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Texcell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Texcell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Texcell.
Texcell financials insights
Gather financial insights about Texcell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Texcell Tech Stack
A closer look at the technologies used by Texcell
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Event
Research & Development, Bioengineering, Medical Research, Clinical Operations, Operations
Promotion
Executive Move
Left Company
Executive Move
Texcell News & Media
Texcell Unveils State-of-the-Art Viral Clearance Testing Facility
FREDERICK, Md., June 16, 2023 /PRNewswire/ -- Texcell is pleased to announce the opening of their newest testing facility in North America, representing a significant milestone in Texcell's commitment to advancing the viral safety of biotherapeutics and medical devices. Designed to...Valo Therapeutics and Texcell Announce Research Collaboration to Evaluate Immune Responses to PeptiCRAd-1 in Phase I Clinical Study
HELSINKI, Finland and EVRY, France, June 13, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces a collaboration with global contract research organization, Texcell, to investigate immune responses to PeptiCRAd-1 in its Phase 1 clinical study. ValoTx’s PeptiCRAd-1 combines the power of a tumor-specific adenovirus (expressing immune-stimulatory molecules CD40L and OX40L) with immunogenic tumor peptides derived from NY-ESOTexcell Prepares for Expansion: Bolstering Viral Clearance Testing and Patient Safety
FREDERICK, Md., June 12, 2023 /PRNewswire/ -- Texcell – North America has started preparations for the unveiling of their newest viral-clearance focused facility in Frederick, Maryland. The grand opening is scheduled to take place June 16, 2023, preceded by an exclusive luncheon...GTP Bioways and Texcell announce a business partnership to provide extended services to biopharmaceutical companies worldwide
EVRY, France and TOULOUSE, France, March 9, 2023 /PRNewswire/ -- GTP Bioways, a CDMO dedicated to biotherapeutics manufacturing, and Texcell, a CRO specialized in viral safety, assay development, and GMP banking, join forces to provide comprehensive services to biopharmaceutical companies....
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Texcell
Sign Up For FreeTo access detailed company insights
Texcell is a leading specialist in therapeutic safety, partnering with clients to assess virus safety for biopharmaceuticals, including medical devices, biologics, and cell and gene therapies. Their services encompass custom cell culture, cell banking, viral safety, viral clearance studies, and both in vitro and in vivo bioassays. With a mission to... Read More
